What is he best known for?
The fields of study he is best known for:
Glenn W. Kaatz spends much of his time researching Staphylococcus aureus, Microbiology, Efflux, Antibacterial agent and Multiple drug resistance.
His Staphylococcus aureus research is multidisciplinary, incorporating perspectives in Norfloxacin, Antimicrobial and Antibiotics.
Glenn W. Kaatz interconnects Methicillin-resistant Staphylococcus aureus and SCCmec in the investigation of issues within Microbiology.
He has included themes like Clindamycin, Leukocidin, Teicoplanin and Linezolid in his SCCmec study.
His Efflux research includes themes of Ethidium bromide, Ciprofloxacin, Bacteria and Pharmacology.
He studies Vancomycin, focusing on Daptomycin in particular.
His most cited work include:
- Antibacterial and resistance modifying activity of Rosmarinus officinalis (265 citations)
- A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus (152 citations)
- Efflux-Related Resistance to Norfloxacin, Dyes, and Biocides in Bloodstream Isolates of Staphylococcus aureus (151 citations)
What are the main themes of his work throughout his whole career to date?
Glenn W. Kaatz mainly focuses on Microbiology, Staphylococcus aureus, Efflux, Antibacterial agent and Pharmacology.
His study looks at the relationship between Microbiology and topics such as Methicillin-resistant Staphylococcus aureus, which overlap with Clindamycin.
His research integrates issues of Antibiotics, Antimicrobial and Drug resistance in his study of Staphylococcus aureus.
His Efflux research is multidisciplinary, relying on both Ethidium bromide, Multiple drug resistance and Antibiotic resistance, Bacteria.
His study in Antibacterial agent is interdisciplinary in nature, drawing from both Rifampicin, Norfloxacin, Enterococcus faecalis, Staphylococcus and Streptococcus pyogenes.
The various areas that Glenn W. Kaatz examines in his Vancomycin study include Glycopeptide, Lipopeptide and SCCmec.
He most often published in these fields:
- Microbiology (143.00%)
- Staphylococcus aureus (125.00%)
- Efflux (76.00%)
What were the highlights of his more recent work (between 2010-2018)?
- Efflux (76.00%)
- Staphylococcus aureus (125.00%)
- Microbiology (143.00%)
In recent papers he was focusing on the following fields of study:
His main research concerns Efflux, Staphylococcus aureus, Microbiology, Pharmacology and Multiple drug resistance.
The study incorporates disciplines such as Antibacterial activity, Bacteria, Gene and Benzothiazine in addition to Efflux.
His Staphylococcus aureus research is multidisciplinary, incorporating elements of In vitro, Antibiotics, Antibiotic resistance, Antimicrobial and Ethidium bromide.
His work carried out in the field of Microbiology brings together such families of science as Vancomycin and Daptomycin.
The concepts of his Vancomycin study are interwoven with issues in Methicillin-resistant Staphylococcus aureus, Cephalosporin, Pharmacodynamics, Penicillin binding proteins and Lipopeptide.
His work in Pharmacology addresses issues such as Ciprofloxacin, which are connected to fields such as Quantitative structure–activity relationship and Structure–activity relationship.
Between 2010 and 2018, his most popular works were:
- Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. (73 citations)
- Pyrazolo[4,3-c][1,2]benzothiazines 5,5-Dioxide: A Promising New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors (66 citations)
- Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine via efflux pump inhibition. (57 citations)
In his most recent research, the most cited papers focused on:
Staphylococcus aureus, Microbiology, Efflux, Multiple drug resistance and Vancomycin are his primary areas of study.
His research on Staphylococcus aureus frequently links to adjacent areas such as Antimicrobial.
His work in Microbiology covers topics such as In vitro which are related to areas like Glycopeptide, Daptomycin and Lysostaphin.
His Efflux study integrates concerns from other disciplines, such as Antibacterial activity, Structure–activity relationship, Antibacterial agent and Drug resistance.
His Multiple drug resistance study combines topics from a wide range of disciplines, such as Ethidium bromide and Pharmacology.
Glenn W. Kaatz combines subjects such as Synthetic derivatives and Antibiotics with his study of Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
